Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017185087) USE OF THYROID BETA-AGONISTS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/185087 International Application No.: PCT/US2017/029120
Publication Date: 26.10.2017 International Filing Date: 24.04.2017
IPC:
A61K 31/662 (2006.01) ,A61K 31/665 (2006.01) ,A61P 25/28 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
66
Phosphorus compounds
662
Phosphorus acids or esters thereof having P-C bonds, e.g. foscarnet, trichlorfon
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
66
Phosphorus compounds
665
having oxygen as a ring hetero atom, e.g. fosfomycin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
28
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants:
JIANG, Hongjian [CN/CN]; CN
VIKING THERAPEUTICS, INC. [US/US]; 12340 El Camino Real Suite 250 San Diego, California 92130, US
METABASIS THERAPEUTICS, INC. [US/US]; 11119 N. Torrey Pines Road, Suite 200 La Jolla, CA 92037, US
Inventors:
JIANG, Hongjian; CN
LIAN, Brian; US
HANLEY, Rochelle; US
DINERMAN, Misha; US
ERION, Mark; US
BOYER, Serge; US
Agent:
HALSTEAD, David, P.; US
BLOUNT, Jennifer, V.; US
BENNETT, Jonathan, D.; US
AKHIEZER, Alexander; US
ABELLEIRA, Susan, A.; US
Priority Data:
62/326,43622.04.2016US
Title (EN) USE OF THYROID BETA-AGONISTS
(FR) UTILISATION DE BÊTA-AGONISTES DES HORMONES THYROÏDIENNES
Abstract:
(EN) Methods useful for treating X-linked adrenoleukodystrophy are provided.
(FR) L'invention concerne des méthodes utilisées pour traiter l'adrénoleucodystrophie liée à l'X.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)